These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36132130)

  • 1. Identification of a novel necroptosis-related classifier to predict prognosis and guide immunotherapy in breast invasive carcinoma.
    Zhou Q; Xu Y; Shen L; Yang X; Wang L
    Front Oncol; 2022; 12():852365. PubMed ID: 36132130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a robust necroptosis related classifier for colon adenocarcinoma.
    Yang J; Chen H; Wang Y; Chen J
    Front Genet; 2022; 13():965799. PubMed ID: 35991546
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer.
    Pu S; Zhou Y; Xie P; Gao X; Liu Y; Ren Y; He J; Hao N
    Front Immunol; 2022; 13():964118. PubMed ID: 36059470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and validation of a novel necroptosis-related molecular signature to evaluate prognosis and immune features in breast cancer.
    Zhang F; Qi C; Yao Z; Xu H; Zhou G; Li C; Xia H
    Apoptosis; 2023 Dec; 28(11-12):1628-1645. PubMed ID: 37787960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment.
    Song B; Wu P; Liang Z; Wang J; Zheng Y; Wang Y; Chi H; Li Z; Song Y; Yin X; Yu Z; Song B
    Front Genet; 2022; 13():917007. PubMed ID: 35899194
    [No Abstract]   [Full Text] [Related]  

  • 8. Cuproptosis scoring model predicts overall survival and assists in immunotherapeutic decision making in pancreatic carcinoma.
    Liu T; Liu Q; Wang Y; Yang R; Tian F
    Front Genet; 2022; 13():938488. PubMed ID: 36118866
    [No Abstract]   [Full Text] [Related]  

  • 9. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
    Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
    BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
    Luo W; Xiang W; Gan L; Che J; Li J; Wang Y; Han L; Gu R; Ye L; Wang R; Zhang X; Xu Y; Dai W; Mo S; Li Q; Cai G
    J Transl Med; 2022 May; 20(1):235. PubMed ID: 35590418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
    Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
    Front Genet; 2022; 13():919638. PubMed ID: 35783277
    [No Abstract]   [Full Text] [Related]  

  • 13. Development and Validation of a Necroptosis-Related Prognostic Model in Head and Neck Squamous Cell Carcinoma.
    Zhang Z; Hu X; Qiu D; Sun Y; Lei L
    J Oncol; 2022; 2022():8402568. PubMed ID: 35222645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cross-talk of cancer-associated fibroblasts assist in prognosis and immunotherapy in patients with breast carcinoma.
    Gu X; Zheng S; Zhang H; Sun X; Zhou Q
    Cancer Gene Ther; 2022 Dec; 29(12):2001-2012. PubMed ID: 35948763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients.
    Yu H; Lv W; Tan Y; He X; Wu Y; Wu M; Zhang Q
    J Transl Med; 2022 Jul; 20(1):328. PubMed ID: 35864548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Verification of Necroptosis-Related Gene Signature and Associated Regulatory Axis in Breast Cancer.
    Hu T; Zhao X; Zhao Y; Cheng J; Xiong J; Lu C
    Front Genet; 2022; 13():842218. PubMed ID: 35251139
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
    Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
    Front Immunol; 2022; 13():916800. PubMed ID: 35860239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer.
    Zhu J; Wang J; Wang T; Zhou H; Xu M; Zha J; Feng C; Shen Z; Jiang Y; Chen J
    Front Oncol; 2022; 12():955186. PubMed ID: 35965497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer.
    Xin D; Man Y; Yang Y; Wang F
    Front Genet; 2022; 13():953997. PubMed ID: 36092932
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
    He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.